One was based on the detection of pancreatic cancer EV biomarker ephrin type-A receptor 2 [149], while the other obtained a high sensitivity and specificity with the combination of 5 EV markers (one of them being Glypican-1) [150]. Here, GPC1 is linked to pancreatic neoplasm.